Background: Disturbance in calcium metabolism has been suggested in the pathogenesis of hypertension, however, membrane calcium content in humans has not been studied in detail yet in primary hypertension. We compared plasma, intracellular and membrane calcium concentrations in erythrocytes of patients with essential hypertension and in healthy, normotensive control subjects to determine a possible alteration of membrane calcium in primary hypertension. Subjects and Methods: Thirty-four never treated patients with essential hypertension were included and 34 healthy, age-and sex-matched volunteers served as controls. Atomic absorption spectroscopy was used for measurement of intracellular and membrane calcium content in erythrocytes and plasmalemmal preparations.
Introduction
The role of calcium in the pathogenesis of primary hypertension has been extensively investigated. [1] [2] [3] [4] [5] Several investigators observed complex disturbances of calcium metabolism in animal models, cell cultures and patients with hypertension. In humans, increased cytosolic calcium concentrations in platelets and erythrocytes have been described, although data are equivocal. 2, [5] [6] [7] [8] [9] [10] Additionally, animal data suggest disturbed membrane calcium handling in hypertensive rats. 11 Calcium influx across the external cellular membrane in smooth muscle cells and cardiomyocytes plays a crucial role in the control of cellular excitation, contraction and impulse propa-were not significantly different between hypertensives and controls (plasma: 2.59 ؎ 0.18 vs 2.50 ؎ 0.16 mmol/l, intracellular: 1.89 ؎ 0.20 mmol/l vs 1.97 ؎ 0.24 mmol/l, NS resp., mean ؎ s.e.m.). However, membrane calcium content was significantly higher in hypertensive patients compared to control subjects (2.38 ؎ 0.28 mol/g membraneous protein vs 0.86 ؎ 0.32 mol/g membrane protein, P Ͻ 0.01). Membrane calcium content was correlated to mean arterial blood pressure (r ‫؍‬ 0.59, P Ͻ 0.01). Conclusion: Membrane calcium content is significantly increased in patients with untreated primary hypertension and correlates to blood pressure levels. This data suggest, that an membrane mechanism may contribute to alterations in calcium metabolism and to the pathogenesis of primary hypertension. Journal of Human Hypertension (2001) 15, 37-40 gation. Intracellular calcium concentrations are controlled by the reversible binding to specific calcium binding proteins. The calcium flux across the external membrane is regulated by a calcium pump (Ca ++ /Mg ++ -ATPase), calcium channels and calcium binding to the membrane. 12 We recently demonstrated increased membrane calcium content in patients with pre-eclampsia. 13 However, membrane calcium content has not been studied in detail in patients with primary hypertension yet. Membrane calcium may be of importance since altered transmembrane flux of calcium has been suggested in hypertension. Therefore, we measured plasma, intracellular and membrane calcium concentrations in erythrocytes and a possible relation to blood pressure levels. Since antihypertensive treatment has been shown to alter intracellular calcium concentrations, we studied newly diagnosed, never treated patients with primary hypertension and healthy, normotensive control subjects. The aim of the present study was to test the hypothesis that intracellular and membrane
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Patients and methods

Subjects
Our study conforms with the principles outlined in the declaration of Helsinki and was performed in accordance with protocols approved by the local ethics committee at the University of Mü nster. Each subject gave informed consent to participate. Thirtyfour patients with newly diagnosed, primary hypertension and 34 healthy, normotensive, untreated control subjects matched for age and sex were included in this study. Standard laboratory assays were used to determine concentrations of serum creatinine, potassium and natrium. Clinical data of patients and control subjets are shown in Table 1 .
Blood pressure measurements
Left brachial artery blood pressure was measured using an automatic sphygmomanometer (Critikon Dinamap model 1846 SX, Tampa, FL, USA). Measurements were taken in the sitting position, systolic and diastolic blood pressure were assessed three times between 8 and 10 am and the average of the recordings was used to calculate the mean arterial pressure.
Calcium measurements
All calcium measurements in plasma, erythroctes and plasmalemmal membrane preparations were performed using an atomic absorption spectroscope (Thermo Jarrell Ash Video, Thermo Jarrell, Andover, USA). Twenty millilitres of heparinized blood was drawn and centrifugated at 2500 g and plasma for measurements was removed. Intracellular calcium concentrations were determined in red blood cells. The erythrocytes were washed with an isotonic lithium acetate solution adjusted to pH 7.4. Calcium was measured at room temperature after the erythrocyte pellet had been frozen and rethawed in cal- The intra-assay variability was 4.6% in 10 consecutive measurements and the inter-assay variability was between 4 and 7%. Erythrocyte and plasmalemmal membrane preparations were performed as described elsewhere. 10 Briefly, erythrocytes were washed three times by sedimenting in a swinging-bucket rotor (2300 g for 10 min) and the pellet resuspended in 5 mmol/l phosphate buffered saline (150 nmol/l sodium chloride and 5 mmol/l sodium phosphate, pH 8.0). The buffy coat was carefully aspirated each time from the surface of the pellet. Hemolysis was initiated by rapidly and thoroughly mixing of 1 ml packed cells with 40 ml of 5 mmol/l sodium phosphate at pH 8.0.
The membrane ghosts were pelleted by centrifugation at 22 000 g for 10 min in an angle-head rotor. The supernatant was removed with a top aspirator. The tube was tipped and rotated on its axis so that the loose ghosts slid from a small hard button, rich in contaminating proteases, which could then be aspirated. After two more identical cycles the ghost membranes were creamy white and morphologically intact based on previous investigations and on optical control. 10 
The Ca
++ contents were then determined by atomic spectroscopy and referred to membrane protein content. The measurements of protein content were performed using Coomassie Blue (Serva, Deisenhofen, Germany) according to Bradford's method.
14 By this method the confounding influence of differences in hematocrit or amounts of erythrocyte proteins was minimised.
Statistics
Data are expressed as mean Ϯ standard error of the mean (s.e.m.). Linear regression analysis was performed to assess the relationship between calcium concentrations and blood pressure. Comparison between groups was performed by analysis of variance using a post-hoc test (Fisher PLSD). Nominal variables were compared by 2 test. Statistical significance was assumed at two-tailed P-values Ͻ0.05. The power of the study was calculated in cooperation with the Institute of Biomathematics, University of Mü nster. It was assumed, that differences between groups of 20% of the mean are clinically relevant. Previous studies showed that the standard deviations of calcium parameter in several groups are below 30% of the mean. To detect a difference of the mean of 20% between groups with a power of 80% and a type I error of 5% 25 patients in each group are necessary. Table 2 shows plasma, intracellular and membrane calcium concentrations in patients with hypertension and control subjects. There was no significant difference in plasma and intracellular Ca ++ concentrations between patients and control subjects.
Results
In contrast, membrane Ca ++ content was found to be significantly higher in patients with hypertension compared to controls (P Ͻ 0.01). Moreover, membrane calcium content was significantly correlated to mean arterial pressure in hypertensive patients (r ϭ 0.59, P Ͻ 0.01, Figure 1) .
No correlation between plasma, intracellular or membrane calcium and age was observered (P Ͼ 0.05 respectively). Additionally, there was no significant difference between hypertensive men and women in plasma, intracellular or membrane calcium concentrations.
Discussion
Several studies demonstrated the occurence of complex disturbances in Ca ++ metabolism in patients with primary hypertension. Most studies focused on plasma and cytosolic, intracellular calcium concentrations. Our study demonstrates a significantly elevated calcium content in cell membranes of erythrocytes in patients with primary hypertension compared with normotensive ontrols. Our data are in accordance with results of animal studies, showing abnormal calcium handling by isolated cardiac Figure 1 Erythrocytic membrane calcium concentrations and mean arterial blood pressure in 34 patients with essential hypertension.
Journal of Human Hypertension plasma membranes in spontaneously hypertensive rats. 7, 11 The system of free and bound calcium (approximately 50% of total calcium is bound) represents a calcium buffer. Since plasma and intracellular concentrations were not significantly different in patients, our results suggest, that plasma and intracellular measurements alone may be not adequate in determining calcium metabolism in hypertension. To study the nature of a putative underlying cellular defect in primary hypertension both intracellular and membraneous calcium concentrations have to be considered.
Touyz and co-worker found a relation between mean arterial pressure and intracellular calcium levels. 5 The authors suggested that altered transmembrane transport mechanisms may be related to the level of blood pressure elevation and contribute to cellular cation changes and pathogenesis of hypertension. Our results of increased membrane calcium content in hypertensive patients support the hypothesis of a role of membrane cation transport disturbance in the pathogenesis of hypertension. Moreover, we found a relation between mean arterial pressure and calcium membrane content in hypertensive patients. However, this relation has to be interpreted with caution since clinical and metabolic factors not controlled in our study may have influenced the results. Therefore, a causal-effect relation can not be suggested and was not adressed by the design of our study. Erne and coworkers described an correlation of platelet calcium with blood pressure levels and found a parallel reduction of intra-platelet calcium and blood pressure during therapy by calcium-entry blockers. 8 Some other studies also reported increased intraplatelet and intralymphocytic calcium concentrations in hypertensive subjects and parellel reductions in blood pressure and intracellular calcium during calciumblocker therapy. 2, [15] [16] [17] However, these abnormalities are not shared by all hypertensive subjects. 17 In our study, intracellular calcium concentrations were not significantly different in hypertensive patients compared to controls. This discrepancy may be explained by differences in the physiology of the studied blood cells, eg, platelets, lymphocytes and erythrocytes.
It has been shown that antihypertensive treatment can alter intracellular calcium concentrations. In animal studies and in humans a decrease of intracellular calcium in platelets and thymocytes has been demonstrated after therapy by several antihypertensive agents. 2, 16 We therefore only included newly diagnosed hypertensive patients, who had never been treated for hypertension.
The mechanisms responsible for increased membrane calcium content remain unclear. Toyz and coworker reported alteration in calcium binding to the outer cell membranes of erythrocytes in hypertensive patients and an influence of magnesium levels on calcium binding. 18 As a hypothesis, alterations of magnesium concentrations and a changed cell membrane ATPase activity may play a role. An interaction between Mg ++ and Ca ++ at the membrane level has been suggested to interfere with calcium homoeostasis by altering ATPase and Ca ++ ATPase activities. 19 We could recently demonstrate significantly decreased membrane Mg ++ concentrations in a subgroup of patients with essential hypertension. 10 However, these parameters were not measured in the present study and contribution of the mentioned factors remains speculative.
An influence of race and sex with disturbance in membrane calcium binding being more pronounced in males and black subjects has been reported. 18 However, we did not observe a difference between men and women in our hypertensive patients.
We recently reported elevated calcium membrane content in patients with pre-eclampsia. In primary hypertension, we did not observe decreased plasma calcium levels seen in pre-eclamptic patients. 13 However, the similar alterations of membrane calcium observed in patients with primary hypertension may suggest a similar membrane mechanism contributing to the disturbed calcium metabolism in both hypertensive disorders.
We conclude that the calcium content of erythrocytic cell membranes is increased in patients with primary hypertension. A membrane mechanism may be a causal link in the pathophysiology of the observed alterations in calcium metabolism in hypertension.
